The Role of Functional Magnetic Resonance Imaging in Preoperative Assessment of Primary Penile Carcinoma

Recruiting Observational Study
Penile Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Male
Study type
Observational
Participants needed
60 (estimated)
Sponsor
Oslo University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The proposed project is intended as a prospective study that includes 60 patients with newly diagnosed penile squamous cell carcinoma (SCC) referred to Oslo University Hospital (OUH), Radiumhospitalet, for surgery, primarily organ-sparing surgery (OSS). OSS may improve not only quality of life, but also quality of sexual function. However, there is a potential for increased risk of local recurren…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * newly diagnosed penile squamous cell carcinoma (SCC) * the patient will benefit from organ-sparing surgery (OSS) * signed broad consent for cancer research Exclusion Criteria: * N/A
Contacts

Marta D Switlyk, MD PhD

47 915 02 770

marswi@ous-hf.no

CONTACT